Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seer Inc Cl A (NQ: SEER ) 2.065 +0.005 (+0.24%) Streaming Delayed Price Updated: 1:23 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 159,001 Open 2.100 Bid (Size) 2.060 (106) Ask (Size) 2.070 (22) Prev. Close 2.060 Today's Range 2.065 - 2.124 52wk Range 1.455 - 5.125 Shares Outstanding 65,088,575 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 July 18, 2024 From Seer, Inc. Via GlobeNewswire Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery June 11, 2024 From Seer, Inc. Via GlobeNewswire Performance YTD +6.44% +6.44% 1 Month +21.47% +21.47% 3 Month +18.00% +18.00% 6 Month +22.19% +22.19% 1 Year -58.86% -58.86% More News Read More Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study June 02, 2024 From Seer, Inc. Via GlobeNewswire Recap: Seer Q4 Earnings February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Seer Reports First Quarter 2024 Financial Results May 08, 2024 From Seer, Inc. Via GlobeNewswire Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions May 08, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report First Quarter 2024 Financial Results on May 8, 2024 April 23, 2024 From Seer, Inc. Via GlobeNewswire Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook February 29, 2024 From Seer, Inc. Via GlobeNewswire Seer to Participate in the TD Cowen 44th Annual Health Care Conference February 21, 2024 From Seer, Inc. Via GlobeNewswire Zoom Video And 2 Other Stocks Insiders Are Selling February 08, 2024 Via Benzinga Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery February 06, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 February 01, 2024 From Seer, Inc. Via GlobeNewswire Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference December 21, 2023 From Seer, Inc. Via GlobeNewswire Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum November 10, 2023 From Seer, Inc. Via GlobeNewswire Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 November 08, 2023 From Seer, Inc. Via GlobeNewswire Seer Reports Third Quarter 2023 Financial Results November 07, 2023 From Seer, Inc. Via GlobeNewswire Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program November 01, 2023 From Seer, Inc. Via GlobeNewswire Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 October 19, 2023 From Seer, Inc. Via GlobeNewswire Earnings Scheduled For November 7, 2023 November 07, 2023 Via Benzinga 7 Contrarian Stocks to Buy for the High-Stakes Gambler September 28, 2023 Via InvestorPlace Stocks That Hit 52-Week Lows On Thursday September 21, 2023 Via Benzinga Seer to Participate in Upcoming September Investor Conferences September 08, 2023 From Seer, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday August 23, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
